MODERNA and Pfizer COMPLETE APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR EMERGENCY USE AUTHORIZATION OF OMICRON-TARGETING BIVALENT COVID-19 BOOSTER VACCINE.
The new mRNA vaccines expected to be authorized next month. The catch?
There is no clinical trial results that are public. There were no trials for new booster at all